With a strong focus on healthcare and biotechnology, icometrix stands as a promising player in the field, leveraging the power of AI to transform patient care and aid in neurological research and treatment.
icometrix
a GE HealthCare company
Founded 2011
Belgium
46 employees
Grant
Total: $21.42M
Biotechnology, Health Care
Belgium
46 employees
Grant
Total: $21.42M
Biotechnology, Health Care
General Information
Company Name
icometrix
Founded Year
2011
Location
Belgium
Belgium
Founders / Decision Makers
Employees
46
Industries
Biotechnology, Health Care
Funding Stage
Grant
Social
BounceWatch is an independent company data service, not affiliated with icometrix. To contact icometrix, visit icometrix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does icometrix compare?
A PDF of icometrix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting icometrix soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is icometrix on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Belgium Market
Biotechnology
About icometrix
Business keywords: Medical Imaging, Neurological Disorders, Radiological Reporting, Clinical Management, Multiple Sclerosis, Brain Trauma, Epilepsy, Stroke, Dementia, Alzheimer's Disease, Digital Health, COVID-19, Drug Research
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | Undisclosed | 1 |
|
17 Mar 2023 |
| Grant | £1.42M | 1 |
NHS England
|
03 Mar 2023 |
| Series A | $18.00M | 3 |
|
14 May 2019 |
| Venture Round | €2.00M | - |
|
13 Jan 2016 |
icometrix Alternatives & Competitors
View All Alternatives
icometrix vs
MedRhythms, Inc.
United States
Creating a world where everyone with neurologic injuries and diseases has access to the highest qual...
Venture round
51 employees
Biotechnology, Health Care
icometrix vs
IXICO
United Kingdom
Precision in neuroscience
Post-IPO Equity
96 employees
Biotechnology, Health Care
icometrix vs
Lys Therapeutics
France
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle n...
Non Equity Assistance
13 employees
Biotechnology, Health Care
FAQ About icometrix
a GE HealthCare company
icometrix was founded in 2011.
icometrix is headquartered in Belgium.
icometrix operates in Biotechnology and Health Care. Its work centres on Medical Imaging, Neurological Disorders, Radiological Reporting and Clinical Management.
icometrix has approximately 46 employees.
icometrix has completed 4 funding rounds, raising a total of $21.42M. The latest funding stage is Grant.
Top alternatives and competitors to icometrix include MedRhythms, Inc., IXICO, Lys Therapeutics, Imeka, Novoic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
icometrix and MedRhythms, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for icometrix, https://www.bouncewatch.com/company/icometrix, updated 25 September 2026. When citing, please name BounceWatch and link this page.
